Exelixis Inc (EXEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXEL | ASND | BMRN | ||
| Company | Exelixis Inc | Ascendis Pharma ADR | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 53.74 | 253.62 | 67.55 | ||
| High | 54.68 | 257.89 | 68.34 | ||
| Low | 53.70 | 252.87 | 66.52 | ||
| Last | 54.08 | 253.29 | 66.70 | ||
| Change | +0.39 | -1.52 | -0.98 | ||
| Percent Change | +0.73% | -0.60% | -1.45% | ||
| Volume | 1,949,700 | 363,700 | 1,593,600 | ||
| 20-Day Average Volume | 2,754,015 | 544,965 | 2,308,310 | ||
| Previous | 53.69 | 254.81 | 67.68 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 53.74 | 250.84 | 64.61 | ||
| 20-Day Raw Stochastic | 58.92% | 62.27% | 64.60% | ||
| 20-Day Relative Strength | 51.37 | 51.66 | 59.64 | ||
| Weighted Alpha | +41.29 | +29.51 | +22.10 | ||
| Today's Opinion | 56% Buy | 72% Buy | 100% Buy | ||
| Yesterday's Opinion | 40% Buy | 72% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.54% since 08/14/26 | +1.93% since 08/14/26 | -0.98% since 08/14/26 | ||
| Low | 50.81 on 08/17/26 | 242.00 on 08/17/26 | 66.21 on 08/17/26 | ||
| High | 54.68 on 08/21/26 | 261.61 on 08/19/26 | 69.62 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | -3.64% since 07/21/26 | -0.75% since 07/21/26 | +12.65% since 07/21/26 | ||
| Low | 49.97 on 08/13/26 | 239.56 on 08/04/26 | 57.42 on 07/23/26 | ||
| High | 56.95 on 08/05/26 | 261.61 on 08/19/26 | 70.98 on 08/12/26 | ||
| 3-Month | |||||
| %Chg | +8.92% since 05/21/26 | +2.34% since 05/21/26 | +23.29% since 05/21/26 | ||
| Low | 48.10 on 06/03/26 | 203.80 on 06/08/26 | 52.19 on 05/28/26 | ||
| High | 57.57 on 07/07/26 | 282.15 on 07/09/26 | 70.98 on 08/12/26 | ||
| 6-Month | |||||
| %Chg | +23.95% since 02/20/26 | +12.57% since 02/20/26 | +4.09% since 02/20/26 | ||
| Low | 39.71 on 03/02/26 | 203.80 on 06/08/26 | 49.26 on 05/18/26 | ||
| High | 57.57 on 07/07/26 | 282.15 on 07/09/26 | 70.98 on 08/12/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,303,414 | 15,894,281 | 13,101,089 | ||
| Shares Outstanding, K | 247,782 | 62,377 | 193,574 | ||
| Annual Sales, $M | 2,320,130,000 | 814,760,000 | 3,221,250,000 | ||
| Annual Net Income, $M | 782,570,000 | -258,000,000 | 348,900,000 | ||
| Last Qtr Sales, $M | 628,690,000 | 394,490,000 | 989,710,000 | ||
| Last Qtr Income, $M | 212,050,000 | 240,640,000 | 44,760,000 | ||
| 60-Month Beta | 0.44 | 0.39 | 0.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.91 on 08/05/26 | 3.29 on 08/13/26 | 1.20 on 08/06/26 | ||
| Latest Earnings Date | 11/03/26 | 11/11/26 | 10/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 17.21 | 144.23 | 41.27 | ||